Kidney Medicine · Dec 11, 2025

Systematic Review and Meta-analysis of the Predictive Performance of Stroke and Bleeding Prediction Models in Atrial Fibrillation Patients With Kidney Disease

By Langenhuijsen LFS, Derksen DCL, Milders J et al.

RATIONALE & OBJECTIVE: Patients with atrial fibrillation (AF) and chronic kidney disease (CKD) are at high risk for ischemic stroke (IS) and bleeding. The applicability of prediction models in this population remains debated. This study aimed to (1) identify external validations of CHA₂DS₂-VASc, CHADS₂, HAS-BLED, and HEMORR₂HAGES model scores in patients with AF undergoing dialysis or with CKD, (2) provide pooled estimates, and (3) assess their risk of bias (ROB). STUDY DESIGN: Systematic review and meta-analysis. SETTING & PARTICIPANTS: We searched Web of Science, PubMed, MEDLINE, Embase, Emcare, PMC, Cochrane Library, and Academic Search Premier for studies externally validating IS and bleeding prediction models in patients with AF undergoing dialysis or with CKD. EXPOSURES: AF and CKD or dialysis. OUTCOMES: IS and bleeding. ANALYTICAL APPROACH: Eligible studies were reviewed, discrimination was pooled using random-effects meta-analysis, calibration was calculated and plotted, and the ROB score was assessed using the prediction model ROB assessment tool. RESULTS: The CHA₂DS₂-VASc score was validated in 35 studies, the CHADS₂ and HAS-BLED scores in 19 each, and the HEMORR₂HAGES score in 1. Among 627,199 patients, 28,493 (4.5%) experienced IS and 25,695 (4.1%) bleeding. Only 12 studies presented c-statistic scores. In patients with AF and CKD, the CHADS₂ model score showed nominally better discrimination predicting IS (pooled c-statistic score of 0.70) than the CHA₂DS₂-VASc model score (0.64). In patients with AF undergoing dialysis, the CHA₂DS₂-VASc and CHADS₂ model scores showed similar discrimination predicting IS (both 0.70), and the HAS-BLED and HEMORR₂HAGES model scores showed similar c-statistic scores predicting bleeding (0.55 and 0.56, respectively). Calibration was good in the most relevant high-risk group. LIMITATIONS: All studies were at high ROB scores, contained within- and between-study heterogeneity, and often merged scoring categories or populations, limiting comparability. CONCLUSIONS: Although modest, the discrimination of prediction models in patients with AF undergoing dialysis or with CKD is similar to patients with AF without CKD. Despite the described limitations, these models can be used in clinical practice for patients with CKD and patients undergoing dialysis.

doi.org/10.1016/j.xkme.2025.101200Open accessPubMed 41630994Biomarkers

AgingResearch.News